Suspected Metastatic Disease on Radiology Reports: What It Means
“Suspected metastatic disease” on a radiology report means that the cancer may have spread from its original site to another part of the body. This phrase signals concern, not certainty. This article will discuss what it means on imaging tests, why radiologists use this wording, and what typically happens next.
“Suspected metastatic disease”: plain meaning
-
Metastasis means cancer cells have moved to another organ or tissue and formed new growths.
-
Suspected means imaging shows features that fit metastasis, but more information is needed (clinical details, comparison scans, or a biopsy) to make it definite.
-
Reports use cautious wording because imaging suggests, but does not prove, a diagnosis.
Imaging tests used to look for metastasis
CT scan (computed tomography).
CT is a common first-line test to evaluate the body. CT can show lung nodules, liver lesions, enlarged lymph nodes, bone lesions, and other organ findings.
MRI (magnetic resonance imaging).
MRI is excellent for the brain, liver, spine, pelvis, and soft tissues. It helps show small lesions, marrow involvement, and whether something is solid, cystic, or blood-filled.
PET/CT (positron emission tomography).
PET/CT highlights areas with higher sugar uptake (FDG avidity), which can indicate active tumor. It helps find disease sites not obvious on CT alone and assesses how “metabolically active” a lesion is.
Bone scan (nuclear medicine).
Bone scintigraphy detects areas of new bone turnover, often used for cancers that spread to bone (prostate, breast, lung).
Ultrasound and X-ray.
Ultrasound evaluates liver, neck nodes, soft-tissue masses, and guides biopsies. X-rays can show lytic (bone loss) or sclerotic (bone-forming) changes and fractures.
Why a report says “suspected”: how radiologists decide
Radiologists weigh several features:
-
Location typical for spread. Example: liver lesions in colorectal cancer, lung nodules in many cancers, bone lesions in prostate or breast cancer.
-
Number and pattern. Multiple lesions in different areas raise concern more than a single tiny indeterminate spot.
-
Appearance.
-
Liver metastases on CT/MRI: often round, variable enhancement, sometimes rim-enhancing.
-
Lung metastases on CT: multiple round nodules.
-
Bone metastases: can be lytic (bone destruction) or sclerotic/blastic (bone forming); prostate cancer commonly blastic, renal and thyroid often lytic.
-
Brain metastases: usually multiple enhancing lesions with surrounding edema on MRI.
-
-
Metabolic activity on PET/CT. High FDG uptake can support—but not by itself prove—metastasis.
-
Growth over time. Changes on follow-up imaging often clarify uncertain findings.
-
Clinical context. Known primary cancer, tumor markers, symptoms, and prior treatments influence interpretation.
Common metastatic patterns by organ (imaging focus)
-
Liver metastases: Seen on CT/MRI as round lesions that may enhance less than the surrounding liver or show rim enhancement.
-
Lung metastases: Multiple bilateral nodules; sometimes cavitary or air filled. CT is best to characterize size and number.
-
Bone metastases:
-
Lytic: holes or thinning in bone, risk of fracture.
-
Sclerotic/blastic: denser patches of bone.
-
MRI shows early marrow involvement before X-ray changes.
-
-
Brain metastases: Ring-enhancing or solid enhancing lesions with edema; MRI with contrast is most sensitive.
-
Lymph nodes: Enlarged, rounded nodes or nodes with abnormal internal features on CT/MRI; FDG-avid nodes on PET/CT raise suspicion even if not enlarged.
Metastasis mimics: reasons not to panic
Several noncancer conditions can look similar:
-
Infections and inflammation can cause enhancing lesions in the liver or brain and FDG uptake on PET/CT.
-
Hemangiomas and cysts in the liver are common and usually benign, but atypical ones can look suspicious.
-
Healed bone injuries or arthritis can be sclerotic or FDG-avid.
-
Drug effects and post-treatment change (radiation fibrosis, ablation zones) may mimic metastases.
-
Technical factors (breathing motion, artifact, contrast timing) can make structures look abnormal.
Because of these look-alikes, radiologists and other doctors will correlate with prior scans, lab results, or suggest a targeted follow-up study.
What happens after a “suspected metastatic disease” report
1) Correlate with history. Your oncology team considers symptoms, tumor markers, and prior imaging.
2) Compare with older scans. Stable findings over months are less concerning; new or growing lesions are more worrisome.
3) Get targeted imaging. For example, liver MRI for liver lesions, or contrast brain MRI for suspected brain metastasis.
4) Consider biopsy. When results would change treatment, a minimally invasive image-guided biopsy may be recommended.
5) Update the staging. If confirmed, findings help define the cancer stage and guide therapy.
How radiology reports phrase uncertainty
Radiologists use graded language to match the level of concern:
-
“Indeterminate” or “too small to characterize” for very small or unclear findings.
-
“Suspicious for metastasis” when features are concerning but not definitive.
-
“Consistent with metastasis” when imaging strongly supports the diagnosis, often in the appropriate clinical context.
-
Recommendations may include PET/CT, MRI, short-interval follow-up, or biopsy.
PET/CT and SUV: what the numbers mean
PET/CT reports often mention SUV (standardized uptake value). Higher SUV suggests increased metabolic activity. Important points:
-
SUV is helpful, not absolute. Infection and inflammation can also have high SUV.
-
Trends matter. Rising or falling uptake over time can show response or progression.
-
Thresholds vary. There is no single SUV number that “proves” metastasis across all cancers.
Follow-up imaging: what to expect
If a lesion is small or borderline, your team may recommend repeat imaging:
-
Short-interval CT or MRI to look for growth.
-
Problem-solving MRI (for liver, bone marrow, or brain) when CT is unclear.
-
Biopsy planning with ultrasound or CT if confirmation will alter treatment.
-
Functional follow-up with PET/CT after starting therapy to gauge response.
Practical questions to ask your care team
-
Which organs show the suspicious findings?
-
How confident are we that these are metastases versus benign or treatment-related changes?
-
What is the next best test: MRI, PET/CT, short-interval follow-up, or biopsy?
-
If confirmed, how would it change staging and treatment?
-
Can we compare with prior scans from other hospitals?
Key takeaways
-
“Suspected metastatic disease” means imaging findings are concerning for cancer spread, but not yet proven.
-
CT, MRI, PET/CT, bone scan, ultrasound, and X-ray each contribute different clues.
-
Noncancer conditions can mimic metastasis, so follow-up, comparison with prior scans, or biopsy may be needed.
-
Clear next steps usually include targeted imaging, short-interval follow-up, or image-guided biopsy when it will change care.
Conclusion
A report that mentions “suspected metastatic disease” means there is concern but no definite evidence for spread of cancer. Targeted studies like MRI, follow up imaging, PET CT scans and biopsies can confirm the diagnosis. Understanding what the radiologist means by mentioning “suspected metastatic disease” can help you have more informed discussions with your doctor.
References
https://www.cancer.gov/types/metastatic-cancer
https://www.radiologyinfo.org/en/info/pet